McKesson Co. (NYSE:MCK) is Tilia Fiduciary Partners Inc.’s 9th Largest Position

Tilia Fiduciary Partners Inc. lifted its holdings in shares of McKesson Co. (NYSE:MCK) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,202 shares of the company’s stock after acquiring an additional 313 shares during the quarter. McKesson accounts for about 2.0% of Tilia Fiduciary Partners Inc.’s investment portfolio, making the stock its 9th biggest position. Tilia Fiduciary Partners Inc.’s holdings in McKesson were worth $2,965,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Distillate Capital Partners LLC raised its stake in shares of McKesson by 127,542.9% in the 2nd quarter. Distillate Capital Partners LLC now owns 35,740 shares of the company’s stock valued at $20,874,000 after purchasing an additional 35,712 shares in the last quarter. Chase Investment Counsel Corp raised its stake in McKesson by 50.8% during the second quarter. Chase Investment Counsel Corp now owns 8,985 shares of the company’s stock valued at $5,247,000 after buying an additional 3,027 shares in the last quarter. Wealthspire Advisors LLC grew its position in shares of McKesson by 8.9% in the 2nd quarter. Wealthspire Advisors LLC now owns 1,623 shares of the company’s stock worth $948,000 after acquiring an additional 133 shares in the last quarter. Vaughan David Investments LLC IL bought a new stake in shares of McKesson in the 2nd quarter valued at approximately $238,000. Finally, Newbridge Financial Services Group Inc. raised its position in shares of McKesson by 2,143.1% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 1,458 shares of the company’s stock valued at $851,000 after acquiring an additional 1,393 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity

In related news, EVP Leann B. Smith sold 579 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares of the company’s stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.11% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MCK shares. Mizuho initiated coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price objective for the company. Evercore ISI boosted their price objective on shares of McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a research report on Thursday, November 7th. Bank of America dropped their price objective on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday. Citigroup decreased their target price on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research note on Friday. Finally, Baird R W upgraded McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $646.14.

McKesson Trading Down 1.4 %

MCK stock traded down $8.53 during trading on Friday, hitting $581.73. The company had a trading volume of 593,906 shares, compared to its average volume of 588,276. The firm has a market capitalization of $73.84 billion, a price-to-earnings ratio of 30.13, a P/E/G ratio of 1.25 and a beta of 0.52. The business has a 50 day moving average of $591.44 and a 200 day moving average of $561.65. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business had revenue of $93.65 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the firm posted $6.23 earnings per share. The business’s revenue was up 21.3% on a year-over-year basis. As a group, equities analysts predict that McKesson Co. will post 32.73 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd were paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date of this dividend was Monday, December 2nd. McKesson’s dividend payout ratio is presently 14.71%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.